Search

Author/Creator Dao, Feng‐Ting

1. Combination of KIT and FLT3‐ITD mutation status with minimal residual disease levels guides treatment strategy for adult patients with inv(16) acute myeloid leukemia in first complete remission. Issue 4 (15th May 2022)

Authors:
Wang, Jun; Dao, Feng‐Ting; Wang, Yu; Jiang, Hao; Xu, Lan‐Ping; Zhao, Xiao‐Su; Zhang, Xiao‐Hui; Liu, Kai‐Yan; Huang, Xiao‐Jun; Jiang, Qian; Qin, Ya‐Zhen
Journal:
Hematological oncology
Issue:
Volume 40:Issue 4(2022)
Page Start:
724
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemia. (30th July 2019)

Authors:
Yang, Lu; Chen, Wen‐Min; Dao, Feng‐Ting; Zhang, Yan‐Huan; Wang, Ya‐Zhe; Chang, Yan; Liu, Yan‐Rong; Jiang, Qian; Zhang, Xiao‐Hui; Liu, Kai‐Yan; Huang, Xiao‐Jun; Qin, Ya‐Zhen
Journal:
Cancer medicine
Issue:
Volume 8:Number 12(2019:Sep.)
Page Start:
5459
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search